|
Name |
3-Phenyl-propenal
|
Molecular Formula | C9H8O | |
IUPAC Name* |
3-phenylprop-2-enal
|
|
SMILES |
C1=CC=C(C=C1)C=CC=O
|
|
InChI |
InChI=1S/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H
|
|
InChIKey |
KJPRLNWUNMBNBZ-UHFFFAOYSA-N
|
|
Synonyms |
3-phenyl-propenal; Aldehyd skoricovy; formylstyrene; NSC 16935; 3-phenyl-prop-2-enal; DSSTox_CID_4835; Propenaldehyde, 3-phenyl-; 3-phenyl-2-propen-1-one; DSSTox_RID_83510; DSSTox_GSID_24835; 2-Propenaldehyde, 3-phenyl-; SCHEMBL5817749; CHEMBL3187944; DTXSID1024835; Tox21_200272; AKOS025243266; NCGC00257826-01; CAS-104-55-2; DB-003616; FT-0631572; FT-0696806; FT-0697676
|
|
CAS | 104-55-2 | |
PubChem CID | 307 | |
ChEMBL ID | CHEMBL3187944 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 132.16 | ALogp: | 1.9 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.446 |
Caco-2 Permeability: | -4.467 | MDCK Permeability: | 0.00002120 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.004 |
Blood-Brain-Barrier Penetration (BBB): | 0.981 | Plasma Protein Binding (PPB): | 87.87% |
Volume Distribution (VD): | 1.629 | Fu: | 11.54% |
CYP1A2-inhibitor: | 0.938 | CYP1A2-substrate: | 0.29 |
CYP2C19-inhibitor: | 0.234 | CYP2C19-substrate: | 0.664 |
CYP2C9-inhibitor: | 0.104 | CYP2C9-substrate: | 0.686 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.838 |
CYP3A4-inhibitor: | 0.007 | CYP3A4-substrate: | 0.242 |
Clearance (CL): | 5.501 | Half-life (T1/2): | 0.813 |
hERG Blockers: | 0.032 | Human Hepatotoxicity (H-HT): | 0.365 |
Drug-inuced Liver Injury (DILI): | 0.146 | AMES Toxicity: | 0.869 |
Rat Oral Acute Toxicity: | 0.743 | Maximum Recommended Daily Dose: | 0.484 |
Skin Sensitization: | 0.96 | Carcinogencity: | 0.535 |
Eye Corrosion: | 0.511 | Eye Irritation: | 0.993 |
Respiratory Toxicity: | 0.953 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000012 | 0.625 | D01ZJK | 0.579 | ||||
ENC001091 | 0.579 | D0L1WV | 0.393 | ||||
ENC001615 | 0.568 | D0X9RY | 0.385 | ||||
ENC001736 | 0.538 | D05OIS | 0.368 | ||||
ENC000204 | 0.529 | D0T3LF | 0.326 | ||||
ENC001616 | 0.500 | D05BMG | 0.326 | ||||
ENC001443 | 0.449 | D0H0HJ | 0.326 | ||||
ENC000053 | 0.447 | D0R1CR | 0.319 | ||||
ENC000801 | 0.404 | D0P9AC | 0.318 | ||||
ENC000052 | 0.400 | D0U0RZ | 0.311 |